Hepatitis C treatment for kidney disease patients
Part of Digestive system, Infections clinical trials.
This study tests whether a new treatment can safely treat hepatitis C in people who also have chronic kidney disease (CKD), including those on dialysis. It aims to help manage hepatitis C while keeping kidney function stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have chronic kidney disease (CKD), whether or not you are on dialysis
- If you are on hemodialysis (a type of dialysis), you must have been on it for at least 6 months
- You must have a hepatitis C infection (genotype 4) with a viral load above 1000 IU/mL
- Your blood counts must be within required limits (white blood cells above 2500/mm3 and platelets above 7500/mm3)
- You cannot be pregnant, nor have HIV or hepatitis B co-infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests antiviral medicine given around the time of a kidney transplant to prevent hepatitis C infection when the donor has hepatitis C. It may help uninfected recipients stay hepatitis C–free after receiving the kidney.
This trial tests whether a very short 4-week course of two hepatitis C drugs (sofosbuvir and glecaprevir-pibrentasvir) can cure hepatitis C in people with early-stage liver disease. The goal is to see if a shorter treatment works as well as longer ones.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This study aims to make hepatitis C treatment simpler and more accessible for people who inject drugs. If you join, you'll receive care that fits your lifestyle and helps cure hep C.
This study tests a pill combination (sofosbuvir/velpatasvir) to cure hepatitis C. It aims to make treatment simple and accessible, and you can join even if you've had treatment before (if it failed or you got reinfected).
This study focuses on screening, treating, and eliminating hepatitis C. It is for people who may be at risk or newly diagnosed, and aims to connect them with care that could help clear the virus.
Hear when a new HCV Infection ( Genotype 4) in CKD Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.